Found: 24
Select item for more details and to access through your institution.
Utilizing Mass Spectrometry to Detect and Isotype Monoclonal Proteins in Urine: Comparison to Electrophoretic Methods.
- Published in:
- Clinical Chemistry, 2023, v. 69, n. 7, p. 746, doi. 10.1093/clinchem/hvad053
- By:
- Publication type:
- Article
A Rapidly Deteriorating Patient with Gross Increase in Serum Free Light Chains.
- Published in:
- Clinical Chemistry, 2019, v. 65, n. 9, p. 1084, doi. 10.1373/clinchem.2018.299008
- By:
- Publication type:
- Article
Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry.
- Published in:
- Clinical Chemistry, 2019, v. 65, n. 8, p. 1015, doi. 10.1373/clinchem.2018.299461
- By:
- Publication type:
- Article
Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.
- Published in:
- Clinical Chemistry, 2016, v. 62, n. 10, p. 1334, doi. 10.1373/clinchem.2015.253740
- By:
- Publication type:
- Article
Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.
- Published in:
- Clinical Chemistry, 2016, v. 62, n. 10, p. 1345, doi. 10.1373/clinchem.2015.253781
- By:
- Publication type:
- Article
Monitoring IgA Multiple Myeloma: Immunoglobulin Heavy/Light Chain Assays.
- Published in:
- Clinical Chemistry, 2015, v. 61, n. 2, p. 360, doi. 10.1373/clinchem.2014.231985
- By:
- Publication type:
- Article
Blood mass spectrometry Detects Residual Disease Better than Standard Techniques in Immunoglobulin light chain amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e313, doi. 10.1016/j.clml.2019.09.514
- By:
- Publication type:
- Article
Going off the “Gold-Standard”: Replacing Electrophoretic Methods With Mass Spectrometry for Plasma Cell Disorders.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e18, doi. 10.1016/j.clml.2017.03.031
- By:
- Publication type:
- Article
A Widely Applicable Method for Resolving Therapeutic Monoclonal Drug Interference for Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e45, doi. 10.1016/j.clml.2017.03.080
- By:
- Publication type:
- Article
Rapid MALDI-TOF Method for Detecting and Isotyping M-Proteins: Evaluation of Paired Samples of Serum and Urine in Different Clinical Settings.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e33, doi. 10.1016/j.clml.2017.03.057
- By:
- Publication type:
- Article
High Sensitivity Detection of Residual Disease in Multiple Myeloma from Blood.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e46, doi. 10.1016/j.clml.2017.03.083
- By:
- Publication type:
- Article
Easy to Use Integrated Software for Detection and Isotyping of Monoclonal Gammopathies via MALDI Mass Spectrometry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e94, doi. 10.1016/j.clml.2017.03.169
- By:
- Publication type:
- Article
Glycosylation of Immunoglobulin Light Chains is Associated with Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e104, doi. 10.1016/j.clml.2017.03.188
- By:
- Publication type:
- Article
Characterizing the Amyloidogenic Protein in Patients Progressing to Light Chain Amyloidosis from Asymptomatic Precursor States Using Mass Spectrometry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e102, doi. 10.1016/j.clml.2017.03.184
- By:
- Publication type:
- Article
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT).
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00624-6
- By:
- Publication type:
- Article
Correction: MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00444-0
- By:
- Publication type:
- Article
Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0291-8
- By:
- Publication type:
- Article
Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E222, doi. 10.1002/ajh.25843
- By:
- Publication type:
- Article
High sensitivity M‐protein detection in a case of light‐chain cardiac amyloidosis without evidence of plasma cell dyscrasia.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. 619, doi. 10.1002/ajh.25383
- By:
- Publication type:
- Article
The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 772, doi. 10.1002/ajh.24772
- By:
- Publication type:
- Article
Correction: Mu heavy chain disease with MYD88 L265P mutation: An unusual manifestation of lymphoplasmacytic lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma.
- Published in:
- Diagnostic Pathology, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13000-022-01244-1
- By:
- Publication type:
- Article
Belantamab mafodotin detection by MASS-FIX and immunofixation.
- Published in:
- 2021
- By:
- Publication type:
- Letter